Table 10: Between-group comparisons (NS vs. CS vs. HA) regarding the length of time to conversion to THR.
X-ray pattern |
Time (month) to conversion to THR |
Comparisons: Treatment 1 vs. Treatment 2 |
p-value* |
|
K/I III-‘A’ |
NS# - M36 |
MMW-HA vs. NS |
48 vs. 36 |
< 0.001 |
MMW-HA# - M48 |
||||
K/L-III’I’ |
NS# - M48 |
MMW-HA vs. NS |
60 vs. 48 |
< 0.001 |
DM# - M48 |
MMW-HA vs. DM |
60 vs. 48 |
< 0.001 |
|
MMW-HA# - MM60 |
NS vs. DM |
48 vs. 48 |
= 1 |
|
K/L-III’H’ |
NS# - M60 |
MMW-HA vs. NS |
72 vs. 60 |
< 0.001 |
DM# - M60 |
MMW-HA vs. DM |
72 vs. 60 |
< 0.001 |
|
MMW-HA# - M72 |
NS vs. DM |
60 vs. 60 |
= 1 |
|
K/L-II’A’ |
NS# - M60 |
MMW-HA vs. NS |
78 vs. 60 |
< 0.001 |
MMW-HA# - M78 |
||||
K/L-II’I’ |
NS# - M72 |
MMW-HA vs. NS |
96 vs. 72 |
< 0.001 |
DM# - M72 |
MMW-HA vs. DM |
96 vs. 72 |
< 0.001 |
|
MMW-HA# - M96 |
NS vs. DM |
72 vs. 72 |
= 1 |
|
K/L-II’H’ |
NS# - M84 |
DM vs. NS |
84 vs. 84 |
= 1 |
DM# - M84 |
NS - control group; MMW-HA - Euflexxa group; DM - Depo Medrol (CS group); # -Each study group included 25 subjects; K/L -I/ II/ III - radiographic grades according to Kellgren-Lawrence; ‘A’ / ’I’ / ’H’ - radiographic patterns (atrophic/intermediate/hypertrophic); *-Mann-Wythney (comparisons between ‘A’-patterns)/Kruskal-Wallis (comparisons between ‘H’ and ‘I’-patterns) tests with Dunn-Bonferroni post hoc analysis.